Viavi Solutions Inc. filings document operating results, material events, governance actions and capital-structure matters for a Nasdaq-listed technology company. Its Form 8-K disclosures include quarterly financial results, material definitive agreements, restructuring-related exit and disposal cost disclosures, and amendments to governing documents.
VIAVI regulatory records also cover senior convertible note transactions, exchanges of prior convertible notes, proxy and governance disclosures, shareholder voting matters, director elections, officer exculpation provisions, common stock registration details and related risk, ownership and corporate-control information.
Viavi Solutions (VIAV) submitted Form 144 reporting proposed insider sales totaling 206,583 shares. The notice lists planned dispositions by Oleg Khaykin and related irrevocable trusts on dates between 02/06/2026 and 02/10/2026, with aggregate proceeds shown as $5,503,089.71.
The securities are Common stock tied to Restricted Stock records; the filing is a notice of proposed sales under Form 144 rather than an executed market trade.
VIAV notice reports an affiliate sale filing under Form 144 for Common Stock consisting of 2,727 shares tied to performance shares, with the filing dated 05/05/2026. The filing also records prior dispositions of 3,551 shares on 03/02/2026 for $116,792.39. The broker/dealer listed is Morgan Stanley Smith Barney LLC and the securities trade on NASDAQ.
VIAV reported proposed sales of Common Stock on a Form 144 by affiliated trusts and an individual. The filing lists multiple proposed or completed transactions in February 2026, including sales of 20,000, 42,767, 73,250, 29,887 and 40,679 shares with dollar amounts shown for each trade.
The seller names include HELEN KHAYKIN IRREVOCABLE TRUST, OLEG KHAYKIN IRREVOCABLE TRUST, and OLEG KHAYKIN, with trade dates in 02/06/2026, 02/09/2026 and 02/10/2026.
Richard E. Belluzzo reported proposed and recent resale activity involving VIAV common stock. The filing lists three tranches of restricted stock awarded on 11/16/2018 (22,148 shares), 11/11/2022 (13,544 shares) and 11/08/2023 (15,418 shares). The filing also discloses two dispositions in February 2026: 15,775 shares on 02/18/2026 for $423,563.48 and 13,058 shares on 02/17/2026 for $345,385.41.
Morgan Stanley Smith Barney LLC Executive Financial Services submitted a Form 144 notice concerning proposed sales of Common stock tied to various equity awards. The filing lists multiple grant types and dates and shows a sale by Kevin Siebert of 7,264 shares on 03/02/2026 for $252,632.48.
VIAVI SOLUTIONS INC. senior vice president and general counsel Kevin Christopher Siebert reported an open-market sale of company common stock. He sold 8,255 shares of common stock at a weighted average price of $54.02 per share, in multiple trades between $53.97 and $54.03. After this sale, he directly holds 20,129 shares of VIAVI common stock.
VIAVI SOLUTIONS INC. director Richard Belluzzo reported an open-market sale of 51,110 shares of common stock. The shares were sold at a weighted average price of $53.30 per share in multiple trades within a narrow price range.
Following this transaction, Belluzzo directly owns 160,740 shares of Viavi common stock. The footnote explains that individual trades were executed between $53.22 and $53.49 per share, with full trade details available upon request.
VIAVI SOLUTIONS INC. President & CEO Oleg Khaykin reported a charitable donation of 5,600 shares of common stock to Carnegie Mellon University. The shares were transferred as a bona fide gift at no stated price, and he continues to hold 1,587,254 shares directly and 20,238 shares indirectly through his spouse.
Viavi Solutions Inc. reported higher revenue but a year-to-date loss as it absorbed major acquisitions and higher financing costs. For the quarter ended March 28, 2026, net revenue rose to $406.8 million from $284.8 million a year earlier, driven mainly by Network and Service Enablement and the acquired Spirent high-speed Ethernet and channel emulation testing business.
Quarterly net income was $6.4 million, down from $19.5 million, while for the first nine months the company posted a net loss of $63.1 million versus income of $26.8 million last year, reflecting a $46.2 million loss on debt extinguishment, higher interest expense and a $36.1 million tax provision. Cash from operations was $47.2 million, but acquisitions led to $417.3 million of net cash used in investing.
Viavi closed the $399.3 million Spirent HSE and CE acquisition and continued integrating Inertial Labs, adding goodwill and intangibles. It funded these moves with a new $600 million Term Loan B and $250.0 million of 0.625% Senior Convertible Notes due 2031, and restructured its older 1.625% convertible notes, including exchanges and conversions into 9.7 million shares. A new fiscal 2026 restructuring plan generated $17.4 million in severance-related charges.
Viavi Solutions Inc reported that Vanguard Capital Management beneficially owned 12,119,145 shares of common stock, representing 5.23% of the class as of 03/31/2026. The filing lists 1,766,338 shares as sole voting power and 12,119,145 as sole dispositive power and is signed by Ashley Grim on 04/30/2026.